Contact
Please use this form to send email to PR contact of this press release:
Atea Pharmaceuticals Announces Chugai In-License of AT-527 from Roche for the Treatment of COVID-19 in Japan
TO:
Please use this form to send email to PR contact of this press release:
Atea Pharmaceuticals Announces Chugai In-License of AT-527 from Roche for the Treatment of COVID-19 in Japan
TO: